Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Molteno Ophthalmic Ltd
WARNING LETTER
•Molteno Ophthalmic Ltd•December 2, 2009

Molteno Ophthalmic Ltd – FDA Warning Letter, Dec 2, 2009

Record Details

The FDA issued a Warning Letter to Molteno Ophthalmic Limited following an inspection from November 30 to December 2, 2009, at their Dunedin, New Zealand facility, which manufactures the Molteno 3 Glaucoma Drainage Device. The inspection revealed that the devices are adulterated under section 501(h) of the Act, as manufacturing methods, facilities, or controls do not conform to the Current Good Manufacturing Practice (CGMP) requirements of the Quality System (QS) regulation (21 CFR Part 820). Specific violations include failures to establish and maintain adequate procedures for corrective and preventative action (CAPA), including analyzing quality data and investigating nonconformities (21 CFR 820.100(a)(1) and (a)(2)). The firm also failed to adequately validate processes where results cannot be fully verified by subsequent inspection (21 CFR 820.75(a)), establish adequate acceptance procedures for in-process product (21 CFR 820.80(c)), validate device design (21 CFR 820.30(g)), and establish procedures for identifying valid statistical techniques (21 CFR 820.250(a)). Additionally, the devices were found to be misbranded under section 502(t)(2) due to the firm's failure to develop, maintain, and implement written Medical Device Reporting (MDR) procedures as required by 21 CFR 803.17. The firm's December 17, 2009 response was deemed inadequate for all observations. Consequently, the devices are subject to refusal of admission into the U.S. (detention without physical examination). Molteno Ophthalmic Limited must provide a written response within fifteen working days detailing specific corrective actions, prevention plans, and a timetable for implementation, with potential re-inspection to verify corrections. Failure to address these issues will impact federal contracts, premarket approvals, and Certificates to Foreign Governments.

Company
Molteno Ophthalmic Ltd
Inspection date
December 2, 2009
Product type
Devices
Office
Center for Devices and Radiological Health
People
  • Timothy A. Ulatowski (Director)
  • Ronald L. Swann (Associate Director )
View Company Profile

ID · c119472e-4c6f-4629-a229-9cba4470eb49

Violation Codes10
21 U.S.C. 321(h)21 U.S.C. 351(h)21 CFR 82021 CFR 820.100(a)(1)21 CFR 820.100(a)(2)21 CFR 820.75(a)21 CFR 820.80(c)21 CFR 820.30(g)21 CFR 820.250(a)21 U.S.C. 352(t)(2)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Molteno Ophthalmic Ltd
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.